Ad
related to: seer antineoplastic drug database download
Search results
Results from the WOW.Com Content Network
Osteoporosis, including drug- and cancer-related osteoporosis, giant cell tumour of bone and hypercalcaemia of malignancies: Hypercholesterolaemia, cataract, urinary retention, hypocalcaemia, osteonecrosis of the jaw and anaphylaxis. Gemtuzumab ozogamicin: IV: CD33 antibody that induces apoptosis of the tagged cell. Acute myeloid leukaemia
There are more than 30 different anti-IGF1R candidate drugs involved in over 70 industry and academic-initiated clinical trials. [6] Dalotuzumab (MK-0646) was developed by Merck and Co., Inc. under license from French pharmaceutical company, Pierre Fabre. [3] Dalotuzumab presently remains in clinical trials and has not been granted FDA approval ...
A cancer registry is a systematic collection of data about cancer and tumor diseases. The data are collected by Cancer Registrars.Cancer Registrars capture a complete summary of patient history, diagnosis, treatment, and status for every cancer patient in the United States, and other countries.
Generally, drugs outlined within the ATC code L01 should be included in this category. Please see WP:PHARM:CAT for more information. Wikimedia Commons has media related to Antineoplastic agents .
This is a list of chemotherapeutic agents, also known as cytotoxic agents or cytostatic drugs, that are known to be of use in chemotherapy for cancer.This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision.
SEER collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 34.6% of the population of the United States. SEER coverage includes 30.0% of African Americans , 44% of Hispanics, 49.3% of American Indians and Alaska Natives , 57.5% of Asians, and 68.5% of Hawaiian/Pacific Islanders ...
Estramustine phosphate, the only dual hormonal and cytostatic antineoplastic agent to have been marketed. A normustine and phosphate ester of estradiol. Used in the treatment of prostate cancer. This is a list of dual hormonal and cytostatic antineoplastic agents.
Tissue-agnostic cancer drugs are antineoplastic drugs that treat cancers based on the mutations that they display, instead of the tissue type in which they appear. [ 1 ] [ 2 ] [ 3 ] Tissue-agnostic drugs that have been approved for medical use include Pembrolizumab , Larotrectinib , Selpercatinib , Entrectinib , and Pralsetinib .
Ad
related to: seer antineoplastic drug database download